SCHEMBL4960487

SCHEMBL4960487

Cc1cc(F)ccc1N(C(=O)[C@H]1CCCNC1)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.39
LMNA P02545 2/20 0.39
CDK9 P50750 3/20 0.39
TACR1 P25103 3/20 0.38
BRD3 Q15059 2/20 0.37
REN P00797 1/20 0.36
CCNT1 O60563 1/20 0.35
SLC6A1 P30531 2/20 0.35
SLC6A11 P48066 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC6A13 Q9NSD5 1/20 0.35
KCNH2 Q12809 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
ABL1 P00519 1/20 0.34
RPLP1 P05386 1/20 0.34
RPLP0 P05388 1/20 0.34
RPS17 P08708 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4963032 0.85 OPRM1 (0.38) OPRM1LMNACDK9RENSLC6A1
SCHEMBL4961968 0.84 LMNA (0.58) OPRM1LMNACDK9SLC6A1SLC6A11
SCHEMBL4962054 0.79 OPRM1 (0.40) OPRM1LMNACDK9SLC6A1SLC6A11
SCHEMBL5772858 0.76 TACR1 (0.39) TACR1BRD3KCNH2SLC6A2SLC6A4
SCHEMBL4961198 0.76 BRAF (0.38) CDK9CCNT1KCNH2RPLP1RPLP0
SCHEMBL4961286 0.75 SLC6A2 (0.50) OPRM1LMNACDK9SLC6A1SLC6A11
SCHEMBL4962731 0.75 TRPM8 (0.41) CDK9RENSLC6A1SLC6A11SMN1; SMN2
SCHEMBL4963040 0.73 CHRM2 (0.52) LMNACDK9SLC6A1SLC6A11TSHR
SCHEMBL4962814 0.73 CHRM2 (0.52) LMNACDK9SLC6A1SLC6A11TSHR
SCHEMBL4961245 0.72 MLYCD (0.41) LMNATACR1SLC6A1SLC6A11TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 EP claimed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 EP claimed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 WO claimed
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 EP disclosed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 EP disclosed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 WO disclosed